Cross-source identifiers
Every current identifier attachment, with the link method and confidence carried verbatim — deterministic links are 1.000; probabilistic links surface their real matcher confidence, never rounded up.
| Scheme | Value | Source table | Link method | Confidence | Since | Provenance |
|---|---|---|---|---|---|---|
| cms_op_profile_id | 8037208 | cms_open_payments | exact_npi_in_open_payments | 1.000 | 2026-06-13 | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-OP-NPI","recipient_profile_id":"8037208"} |
| npi | 1093192486 | nppes_providers | deterministic_pk | 1.000 | 2026-06-11 | evidencerecorded: 2026-06-11 methodology: entity-graph/v1 evidence: {"rule":"D-NPI","source_pk":"1093192486","entity_type_code":"1"} |
| pac_id | 9335474683 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-15 | evidencerecorded: 2026-06-15 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20201002002573","pecos_asct_cntl_id":"9335474683"} |
| pecos_enrlmt_id | I20201002002573 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-15 | evidencerecorded: 2026-06-15 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20201002002573"} |
| pecos_enrlmt_id | I20220308000326 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220308000326"} |
| pecos_enrlmt_id | I20220310000391 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220310000391"} |
| pecos_enrlmt_id | I20220517001429 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220517001429"} |
| pecos_enrlmt_id | I20220519001559 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220519001559"} |
| pecos_enrlmt_id | I20220519002159 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220519002159"} |
| pecos_enrlmt_id | I20220520001000 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220520001000"} |
| pecos_enrlmt_id | I20220614003309 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220614003309"} |
| pecos_enrlmt_id | I20220608001801 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220608001801"} |
| pecos_enrlmt_id | I20220623002567 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220623002567"} |
| pecos_enrlmt_id | I20220728003606 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20220728003606"} |
| pecos_enrlmt_id | I20221014001488 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20221014001488"} |
| pecos_enrlmt_id | I20221030000005 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20221030000005"} |
| pecos_enrlmt_id | I20221118000823 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20221118000823"} |
| pecos_enrlmt_id | I20230209000205 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20230209000205"} |
| pecos_enrlmt_id | I20230309000827 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20230309000827"} |
| pecos_enrlmt_id | I20240219001269 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20240219001269"} |
| pecos_enrlmt_id | I20241001002610 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20241001002610"} |
| pecos_enrlmt_id | I20250425000565 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20250425000565"} |
| pecos_enrlmt_id | I20230419000567 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20230419000567"} |
| pecos_enrlmt_id | I20230510000857 | pecos_providers | exact_npi_in_pecos | 1.000 | 2026-06-16 | evidencerecorded: 2026-06-16 methodology: entity-graph/v1 evidence: {"npi":"1093192486","rule":"D-PECOS","enrlmt_id":"I20230510000857"} |
Graph edges
One-hop relationships — ownership, chain membership, operation — each backed by a federal source row.
| Relationship | Entity | Confidence | Source table | Provenance |
|---|---|---|---|---|
| ← pays | Alexion Pharmaceuticals, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000005462","nature_of_payment":"Food and Beverage"} |
| ← pays | Corium, LLC (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000966856","nature_of_payment":"Food and Beverage"} |
| ← pays | Celgene Corporation (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000343","nature_of_payment":"Food and Beverage"} |
| ← pays | AstraZeneca Pharmaceuticals LP (DE) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000146","nature_of_payment":"Food and Beverage"} |
| ← pays | Biogen, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000193","nature_of_payment":"Food and Beverage"} |
| ← pays | ABBVIE INC. (IL) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000204","nature_of_payment":"Food and Beverage"} |
| ← pays | Eisai Inc. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000136","nature_of_payment":"Food and Beverage"} |
| ← pays | Avadel CNS Pharmaceuticals, LLC (MO) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000786824","nature_of_payment":"Food and Beverage"} |
| ← pays | Grifols USA, LLC (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000005420","nature_of_payment":"Food and Beverage"} |
| ← pays | Alnylam Pharmaceuticals Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000481817","nature_of_payment":"Food and Beverage"} |
| ← pays | Harmony Biosciences LLC (PA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000786822","nature_of_payment":"Food and Beverage"} |
| ← pays | Sarepta Therapeutics, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000181760","nature_of_payment":"Food and Beverage"} |
| ← pays | Kyowa Kirin, Inc. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000010604","nature_of_payment":"Food and Beverage"} |
| ← pays | PFIZER INC. (NY) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-13 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000286","nature_of_payment":"Food and Beverage"} |
| ← pays | Lilly USA, LLC (IN) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000066","nature_of_payment":"Food and Beverage"} |
| ← pays | SCILEX PHARMACEUTICALS INC. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000221799","nature_of_payment":"Food and Beverage"} |
| ← pays | Takeda Pharmaceuticals U.S.A., Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000337","nature_of_payment":"Food and Beverage"} |
| ← pays | Amneal Pharmaceuticals LLC (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000126368","nature_of_payment":"Food and Beverage"} |
| ← pays | UCB, Inc. (GA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000073","nature_of_payment":"Food and Beverage"} |
| ← pays | CATALYST PHARMACEUTICALS, INC. (FL) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000481813","nature_of_payment":"Food and Beverage"} |
| ← pays | MITSUBISHI TANABE PHARMA AMERICA, INC. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000191780","nature_of_payment":"Food and Beverage"} |
| ← pays | Xeris Pharmaceuticals, Inc. (IL) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000781817","nature_of_payment":"Food and Beverage"} |
| ← pays | Neurelis, Inc. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000806859","nature_of_payment":"Food and Beverage"} |
| ← pays | AQUESTIVE THERAPEUTICS, INC. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000501813","nature_of_payment":"Food and Beverage"} |
| ← pays | ACADIA Pharmaceuticals Inc (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000141529","nature_of_payment":"Food and Beverage"} |
| ← pays | Sumitomo Pharma America, Inc. (MA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100001316929","nature_of_payment":"Food and Beverage"} |
| ← pays | JAZZ PHARMACEUTICALS INC. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000005637","nature_of_payment":"Food and Beverage"} |
| ← pays | Teva Pharmaceuticals USA, Inc. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000000141","nature_of_payment":"Food and Beverage"} |
| ← pays | Ultragenyx Pharmaceutical Inc. (CA) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000196876","nature_of_payment":"Food and Beverage"} |
| ← pays | SK Life Science, Inc. (NJ) | 1.000 | cms_open_payments | evidencerecorded: 2026-06-14 methodology: entity-graph/v1 attributes: {"source":"cms_open_payments"} evidence: {"rule":"D-OP-PAYS","record_type":"general","recipient_npi":"1093192486","manufacturer_id":"100000726811","nature_of_payment":"Food and Beverage"} |
Current record
Current claims returned for this entity, grouped by provenance subject. The table exposes the source identifier recorded for each claim.
provider · 1093192486 JSON
Provider screening signals
NPI-keyed source families read directly for 1093192486: federal and state integrity lists, CMS Open Payments, Order and Referring eligibility, Medicare opt-out, and enrollment revalidation. Cells expose the source and provenance fields supplied by the selected record. A screening aid — re-confirm any match against the primary source before acting; absence means nothing on file in the data Fonteum currently holds, never a guarantee none exists.
Sanctions & integrity
Coverage staleExclusion coverage is stale or cannot be reconciled to an attested source artifact. This result is indeterminate and must not be treated as a clearance; check the current issuing-agency lists.
- Coverage status: indeterminate
- Screened 26 integrity lists; no negative determination was made.
14-tuple provenance (26)
Industry payments
On file152 CMS Open Payments records on file. Ask Fonteum for the largest payments and a cited total.
14-tuple provenance (1)
Order & referring eligibility
On fileOn the CMS Order and Referring roster — eligible to order and refer in 5 of 5 Medicare benefit categories.
- Part B: Y
- DME: Y
- HHA: Y
- PMD: Y
- Hospice: Y
14-tuple provenance (1)
Medicare opt-out
None on fileNo CMS Medicare opt-out affidavit on file for this NPI.
14-tuple provenance (1)
Revalidation
On file21 Medicare enrollment records on file.
- Due date: TBD upstream — not due within the ensuing six months.
14-tuple provenance (1)
Point-in-time
Query retained claim coordinates under bitemporal-read/v1. Most facts have no superseded row; dates outside retained coverage may return no prior version, and diffs require both coordinates.
Pick a date to reconstruct, or two dates to diff. Equivalent JSON: /api/v1/history/{subject_type}/{subject_id}?at=… and …/diff?from=…&to=…